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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYColinear HOX expression during hindbrain and spinal cord development diversifies and assigns regional neural phenotypes to discrete
rhombomeric and vertebral domains. Despite the precision of HOX patterning in vivo, in vitro approaches for differentiating human
pluripotent stem cells (hPSCs) to posterior neural fates coarsely pattern HOX expression thereby generating cultures broadly specified
to hindbrain or spinal cord regions. Here, we demonstrate that successive activation of fibroblast growth factor, Wnt/b-catenin, and
growth differentiation factor signaling during hPSC differentiation generates stable, homogenous SOX2+/Brachyury+ neuromesoderm
that exhibits progressive, full colinear HOX activation over 7 days. Switching to retinoic acid treatment at any point during this process
halts colinear HOX activation and transitions the neuromesoderm into SOX2+/PAX6+ neuroectoderm with predictable, discrete HOX
gene/protein profiles that can be further differentiated into region-specific cells, e.g., motor neurons. This fully defined approach signif-
icantly expands capabilities to derive regional neural phenotypes from diverse hindbrain and spinal cord domains.INTRODUCTION
The human genome contains 39 HOX genes divided
among four clusters and classified into 13 paralogous
groups based on sequence homology (Figure 1A). During
embryonic stages of body axis elongation, newly formed
tissues express HOX genes in sequential, contiguous
domains consistent with their order in each cluster, i.e.,
colinearly. This phenomenon is evolutionarily conserved
in bilaterian species and spatially assigns body segment-
specific differentiation trajectories to axial progenitors of
all three germ layers (Lewis, 1978). During formation of
the posterior CNS, progenitors proximal to the node
progressively transition from a 30 to 50 HOX expression
profile as the primitive streak regresses (Iimura and Pour-
quie´, 2006). This process produces nested and overlapping
axial domains of HOX expression within the neuroepithe-
lium of hindbrain rhombomeric (HOX1-5) and spinal
cord cervical (HOX5-9), thoracic (HOX9-10), and lumbosa-
cral (HOX10-13) vertebral segments (Figure 1A) (Philippi-
dou and Dasen, 2013). The spatial variation of HOX
expression along the rostrocaudal (R/C) axis of the poste-
rior CNS diversifies the fates of neuroepithelial progeny
and precisely restricts the development of specific neural
subtypes to discrete axial positions (Philippidou and
Dasen, 2013).632 Stem Cell Reports j Vol. 4 j 632–644 j April 14, 2015 j ª2015 The AuthoRetinoic acid (RA), wingless-type MMTV integration site
protein family (Wnt), fibroblast growth factor (FGF), and
growth differentiation factor (GDF) signaling intricately
regulate HOX expression during posterior CNS develop-
ment (Liu et al., 2001; Nordstro¨m et al., 2006). Yet, it re-
mains controversial how these factors should be applied
to human pluripotent stem cells (hPSCs) to recapitulate
full colinear HOX activation and enable deterministic
patterning of diverse R/C HOX profiles, i.e., regional hind-
brain or spinal cord phenotypes, during neural differentia-
tion. RA is used ubiquitously to caudalize hPSC-derived
neuroectoderm because its secretion by paraxial somitic
mesoderm is believed to convert 30 HOX genes in hindbrain
and spinal cord neural tissues from an epigenetically
repressed to a transcriptionally active state (Gould et al.,
1998; Mazzoni et al., 2013; Bel-Vialar et al., 2002). How-
ever, RA activates HOX1-5 chromatin domains in a salta-
tory (Mazzoni et al., 2013) versus colinear manner, which
patterns mouse (mPSC) and human PSC-derived neuro-
ectoderm with a broad caudal hindbrain thru cervical
spinal cord identity. This is evidenced by demonstra-
tions that RA-mediated caudalization generates HOXB4+
(Li et al., 2008), HOXC4+/HOXA5+/HOXC6/HOXC8
(Mazzoni et al., 2013), HOXC5+/HOXC6+ (Peljto et al.,
2010; Wichterle et al., 2002), or HOXC6+/HOXC8+
(Lee et al., 2007; Li et al., 2005) motor neurons (MNs), orrs
Figure 1. Wnt/b-Catenin and FGF Signaling Synergistically Coordinate HOX Activation during hPSC Differentiation
(A) HOX paralog expression in the hindbrain and spinal cord color-coded to the region where its expression is first detected (modified from
a previous report; Philippidou and Dasen, 2013).
(B) Timeline of H9 hESC differentiation corresponding to (C)–(E).
(C) RT-PCR analysis of cultures at days 2–5.
(D) qPCR analysis at day 5. *p < 0.005; **p < 0.001.
(E) OTX2 and SOX2 expression at day 5 after RA or CHIR treatment. Scale bars, 100 mm. Adjacent images are the same field.
(F) qPCR analysis at day 2 using the H9 ishcat2 line with or without doxycycline treatment. *p < 0.02; **p < 0.005.
(G) qPCR analysis at day 5 using the H9 ishcat2 line with or without doxycycline treatment. *p < 0.02; **p < 0.0001.
All qPCR data are presented as mean ± SD calculated from independent biological triplicates. H9 data are normalized to the condition
yielding maximum expression and ishcat2 data are normalized to each doxycycline-free condition. Statistical significance was calculated
using the Student’s unpaired t test.HOXB4+ astrocytes (Krencik et al., 2011). Alternatively,
Wnt and FGF treatments in the absence of RA can caudalize
neurally differentiating mPSCs by inducing saltatory
activation of HOX1-9 paralogs to coarsely pattern a hetero-
geneous mixture of HOXC6+ cervical and HOXD9+
thoracic spinal tissues, which can be further caudalized
to also contain HOXD10+ lumbar tissues upon GDF11 sup-
plementation (Mazzoni et al., 2013; Peljto et al., 2010).
Also, a recent report demonstrated that manipulation of
Wnt and RA concentrations could yield MNs possessing
hindbrain or rostral spinal phenotypes but more caudal
and further partitioning of regional HOX identity was
not achieved (Maury et al., 2014). Overall, an approachStemfor hPSC neural differentiation that recapitulates the preci-
sion, extent, and predictability of colinear HOX patterning
observed in vivo remains elusive. Its development would
enable unprecedented access to diverse regional pheno-
types that populate posterior CNS tissues and generation
of human disease models containing regional neural
phenotypes with differential susceptibility to neurodegen-
erative disorders (Brockington et al., 2013; Kaplan et al.,
2014; Sandoe and Eggan, 2013).
Recent progress in understanding how the posterior
CNS develops led us to consider other methods for
in vitro HOX patterning. New evidence suggest that bipo-
tent SOX2+/Brachyury(T)+ neuromesodermal progenitorsCell Reports j Vol. 4 j 632–644 j April 14, 2015 j ª2015 The Authors 633
(NMPs) residing in a stem zone proximal to the primitive
streak’s regressing node are the cell source for both the
posterior neural tube and flanking paraxial mesoderm
(Delfino-Machı´n et al., 2005; Takemoto et al., 2011; Tzoua-
nacou et al., 2009). These NMPs are maintained by syner-
gistic Wnt/b-catenin and FGF signaling from the node
and primitive streak that induces SOX2 expression via
activation of enhancer N1 (Takemoto et al., 2006, 2011).
FGF signaling from the node also helps maintain the
NMP state by repressing the expression of the neuroecto-
derm fate determinant PAX6 (Bertrand et al., 2000; Mathis
et al., 2001). As the node regresses, NMPs rostral to the stem
zone experience a decline in FGF signaling, which initiates
paraxial mesoderm differentiation (i.e., somite formation).
Then, the somites secrete RA back to the presumptive
neural tube, which induces PAX6 expression to generate
definitive neuroectoderm of the posterior CNS (Diez del
Corral et al., 2003; Molotkova et al., 2005). The discovery
that Wnt/FGF signaling induces NMPs that progressively
caudalize HOX expression and undergo RA-induced neuro-
ectoderm differentiation to form the hindbrain and spinal
cord suggests an alternative approach for patterning HOX
expression in vitro. Guoti et al. recently had partial success
recapitulating the HOX-expressing NMP state from hPSCs
in vitro, but the NMP phenotype could only bemaintained
for 3 days preventing acquisition of more caudal HOX
genes/proteins before exhibiting amesodermal shift (Gouti
et al., 2014). Also, they were unable to partition HOX
patterning within hindbrain and spinal cord regions.
Therefore, we proceeded to test whether (1) Wnt/b-catenin
and FGF signaling could differentiate hPSCs to stable NMPs
to permit full, colinear activation of HOX genes; (2) RA
exposure could differentiate NMPs to neuroectoderm; (3)
this approach to deriving human neuroectoderm could
enable enhanced control of HOX patterning.
Using a chemically defined, monolayer neural differen-
tiation system (Lippmann et al., 2014), we determined
that by temporally modulating Wnt/b-catenin and FGF
signaling, hPSCs could be differentiated into pure SOX2+/
Brachyury+ NMPs that were stable for 7 days. Over this
period, the NMPs exhibited colinear activation of hind-
brain, cervical, and thoracic HOX genes plus lumbosacral
HOX genes with GDF11 supplementation. At any point
during NMP propagation, a transition to RA was necessary
and sufficient to induce PAX6+/SOX2+ neuroectodermal
differentiation, precisely arrest progressiveHOX activation,
and thereby generate discrete HOX protein profiles indi-
cative of distinct R/C domains. Overall, we demonstrate
the ability to deterministically pattern neuroectoderm
to diverse R/C domains by simply varying the amount
of time NMPs spend under Wnt/b-catenin, FGF, and
GDF signaling prior to RA exposure. Furthermore, we
demonstrate that neuroectoderm of differing HOX expres-634 Stem Cell Reports j Vol. 4 j 632–644 j April 14, 2015 j ª2015 The Authosion profiles produce region-specific hindbrain, cervical,
thoracic, and lumbar MN populations. Therefore, this
temporal biphasic approach could be used to produce
regional neural phenotypes from diverse hindbrain and
spinal cord domains.RESULTS
Regulation of HOX and CDX Expression by RA,
Wnt/b-Catenin, and FGF Signaling
Weused the chemically defined ‘‘E6’’ method to investigate
the effects ofWnt, FGF, RA, andGDF11 during hPSC neural
differentiation because it lacks the use of small molecule
inhibitors that could influence fate choices and does not
form non-neural germ layers that could initiate unknown
signaling crosstalk (Lippmann et al., 2014). We first differ-
entiated H9 human embryonic stem cells (hESCs) in
E6 medium for 24 hr and then added RA, CHIR99021
(CHIR; a small molecule Wnt/b-catenin agonist), FGF8b,
or their relevant combinations and monitored HOX
expression by RT- and quantitative PCR (qPCR) over
4 days (Figures 1B–1D). The addition of RA or CHIR, but
not FGF8b, induced temporal, progressive expression of
HOXA1-HOXC5 (Figure 1C). However, CHIR/FGF8b, but
not RA/FGF8b, accelerated the progression of HOX activa-
tion inducing colinear activation of HOXC6, HOXC8, and
HOXC9 at levels ranging from 39- to 3,400-fold higher
than the other treatments (Figures 1C and 1D). Moreover,
the caudalizing effect of CHIR/FGF8b was not impeded
by the addition of HX531, an RXR inhibitor, and CHIR
but not RA treatment was able to reduce gene and protein
expression of the midbrain/forebrain marker OTX2
(Figures 1C–1E; Figure S1). These results indicate that
while RA can induce some degree of posterior identity
indicated by HOX1-5 expression, CHIR/FGF8b induces
rapid patterning of differentiating hESCs to an OTX2
posterior phenotype with caudal HOX1-9 expression in
an RA-independent manner. This is in agreement with
other neural differentiation studies (Gouti et al., 2014;
Mazzoni et al., 2013)
Additionally, CHIR/FGF8b treatment yielded substan-
tially elevated expression of CDX genes, which are the
upstream regulators of HOX genes (Nordstro¨m et al.,
2006): compared to RA, CHIR/FGF8b upregulated CDX1
by >6-fold, CDX2 by >1,800-fold, and CDX4 by >330-fold
(Figure 1D). To confirm that CHIR-mediated HOX induc-
tion requires b-catenin signaling, we utilized theH9 ishcat2
line, which harbors a doxycycline-inducible b-catenin
small hairpin RNA (shRNA) cassette (Lian et al., 2012).
Addition of doxycycline prior to CHIR treatment reduced
b-catenin (CTNNB1) expression by 3-fold and decreased
HOXA1 and HOXB1 expression by 14- and 15-fold,rs
Figure 2. Colinear HOX Expression in hPSC-Derived NMPs
(A) Analysis of the NMP phenotype by flow cytometry and immunocytochemistry. Gray histogram, immunoglobulin G (IgG) control; red
histogram, label of interest. Scale bars, 100 mm.
(B) Optimized NMP propagation scheme. The addition of CHIR is denoted as t = 0 hr in all panels. Purity of NMPs was assessed by flow
cytometry in the presence or absence of GDF11 (data are presented as mean ± SD). qPCR analysis of HOXD10 and HOXD11 was conducted in
the presence or absence of GDF11 (expression normalized to the time point of maximum expression).
(C) Schematic for HOX induction in NMPs. ‘‘t’’ indicates time under Wnt, FGF, and GDF signaling.
(D) qPCR analysis of colinear HOX expression normalized to the time point of maximum expression. GDF11 was included according to (B).
qPCR data in all panels are presented as mean ± SD calculated from technical duplicates. Full profiles for all analyzed genes can be found in
Figure S2A. For all flow cytometry data, a minimum of two biological replicates was used to calculate mean ± SD.respectively (Figure 1F). In contrast, while doxycycline
treatment also reduced b-catenin by 3-fold in RA-treated
cells, it did not reduce HOXA1 or HOXB1 expression, sug-
gesting RA-mediated induction of HOX transcription is
b-catenin independent (Figure 1F). To verify sustained
b-catenin signaling promotes progressive HOX activation,
we induced HOX expression with CHIR/FGF8b for 1 day
and continued the treatment for 3 days with and without
doxycycline. Doxycycline treatment reduced CTNNB1 by
4-fold, HOXC8 by 2-fold, and HOXC9 by 2-fold, indicating
that sustained b-catenin signaling contributes to progres-
sive HOX activation (Figure 1G).
Derivation of Stable NMPs Exhibiting Full Colinear
HOX Activation
Gouti et al. recently demonstrated that simultaneous
induction of Wnt/b-catenin and FGF signaling can differ-Stementiate hPSCs to SOX2+/Brachyury(T)+ NMPs, but NMPs
persisted for only 3 days before shifting to a mesodermal
fate under their treatment regimen (Gouti et al., 2014).
We observed a similar trend with simultaneous CHIR and
FGF8b treatment inducing uniform Brachyury but also
causing a sharp decrease in SOX2 expression (23% ± 0%
SOX2+), indicating a mesodermal fate shift (Figure 2A,
Route 1). Conversely, pre-treatment with FGF8b prior
to CHIR (pre-FGF8b/CHIR) yielded uniform expression
of both Brachyury and SOX2 that could be maintained
(75%–100% SOX2+/Brachyury+) for 7 days (Figure 2A,
Route 2, and Figure 2B). Thus, FGF signaling upstream
of Wnt/b-catenin signaling effectively induces a stable
NMP identity during hPSC differentiation.
Next, we investigated whether colinear HOX expression
was evident within our NMP cultures. Analogous to their
in vivo counterparts, these cultures exhibited colinearCell Reports j Vol. 4 j 632–644 j April 14, 2015 j ª2015 The Authors 635
activation of HOX genes over the 7-day period (Figures 2B–
2D; Figure S2). In our system, 30 HOX transcripts remained
expressed even after activation of caudal paralogs and fluc-
tuated within an 5-fold range (Figure S2A), also agreeing
with Gouti et al. (2014). Supplementation with GDF11,
a transforming growth factor b (TGF-b) family member
expressed at later stages of NMP propagation in vivo (Liu,
2006; Liu et al., 2001), was necessary for robust activation
of lumbosacral HOX paralogs (Philippidou and Dasen,
2013) (Figures 2B–2D; Figure S2A) but did not significantly
repress transcription of rostral HOX genes (Figure S2B) or
disrupt the NMP state (Figure 2B). Moreover, premature
GDF11 treatment (initiated after 1 day of FGF8b/CHIR)
could induce HOXD10 but at >100-fold lower expression
compared to GDF11 treatment after 4 days of FGF8b/
CHIR, indicating robust lumbosacral patterning requires
prior activation of rostral HOX genes (Figure S2C). We
were able to detect colinear transcription of 33 of the 39
HOX genes in hPSC-derived NMP cultures, excluding
HOXB3, HOXC12, and the HOX13 paralogs, over a time
span consistent with posterior neural tube formation
according to the Carnegie stages of human development
(Figure S2A). Moreover, temporal HOX activation was
also observed in NMPs derived from IMR90-4 iPSCs
(Figure S2D), indicating these mechanisms translate to
other hPSC lines. While we believe the lack of HOXB3
detection was due to experimental or qPCR reagent error,
our extensive literature search was unable to find definitive
documentation of HOXC12 or HOX13 paralog expression
in the posterior CNS (Dasen et al., 2005).
RA Converts NMPs to Neuroectoderm
In vivo, regression of the stem zone along the primitive
streak yields a rostral decline in FGF signaling that coin-
cides with RA secretion from newly formed somites and
PAX6 expression in the newly formed neural tube (Diez
del Corral et al., 2003). This suggests that RA could induce
a NMP-to-neuroectoderm fate switch. To test this in vitro,
we exposed hPSC-derived NMPs to E6 medium containing
RA, CHIR, or neither for 2 days. Cultures exposed to only
E6 medium maintained SOX2 and Brachyury expression
but gained minimal PAX6 (96% ± 4% SOX2+, 15% ± 8%
PAX6+, 78% ± 16% Brachyury+), while exposure to only
CHIR induced a mesodermal fate shift as evidenced by
SOX2 downregulation, no PAX6 induction, and uniform
maintenance of Brachyury expression (50% ± 8% SOX2+,
96% ± 1% Brachyury+) (Figure 3A). However, when
exposed to RA, the cells gained PAX6 expression along
with SOX2 maintenance (98% ± 4% SOX2+, 97% ± 3%
PAX6+) and Brachyury downregulation (43% ± 4%) indi-
cating a neuroectodermal fate shift (Figure 3A). Moreover,
transitioning to RA at any point during NMP propagation
generated a highly pure (>83%) PAX6+/SOX2+ neuroepi-636 Stem Cell Reports j Vol. 4 j 632–644 j April 14, 2015 j ª2015 The Authothelial culture, i.e., polarized N-cadherin, within 4 days
(Figures 3B–3D). If GDF11 was added to facilitate lumbosa-
cral patterning, PAX6 expression in response to RA was
decreased in a dose-dependent manner (Figures S3A–
S3C). The ability of GDF11 to control R/C patterning is
mediated by signaling via ALK5 (Andersson et al., 2006)
and activation of the SMAD2/3 complex (Liu, 2006).
GDF11 has also been shown to activate SMAD1/5/8
in vitro (Liu, 2006), which contributes to dorsal patterning
(Tozer et al., 2013). Since dorsomorphin selectively inhi-
bits ALK2, ALK3, and ALK6, which blocks SMAD1/5/8
signaling (Yu et al., 2008), we hypothesized the addition
of dorsomorphin should prevent acquisition of a dorsal
phenotype without affecting R/C patterning. Indeed, the
addition of dorsomorphin with GDF11 and throughout
RA treatment was sufficient to recover PAX6 expression
(83% ± 4% PAX6+; Figure S3D). Thus, highly pure neuro-
ectoderm cultures could be obtained from NMPs at any
point during colinear HOX activation.
Deterministic Hox Patterning Can Be Achieved Using
a Temporal Transition betweenWnt/FGF/GDF and RA
Treatment
Because RA production in vivo and treatment in vitro coin-
cides with neural differentiation, we and others (Diez del
Corral and Storey, 2004) posited that it might also serve
as a signal to arrest colinear HOX activation. We therefore
tested the ability of RA to generate neuroectoderm with
discrete, region-specific HOX expression profiles in accor-
dance with the status of colinear HOX activation observed
in the NMP state (Figure 3B). Also, we assessed the expres-
sion of HOX transcription factors (TFs) that would demar-
cate distinct hindbrain and spinal cord domains (Dasen
et al., 2003, 2005). First, we evaluated our ability to pattern
neuroectoderm to hindbrain domains using a 0- to 30-hr
FGF8b/CHIR NMP propagation period prior to 4 days of
RA treatment (Figures 3B and 3C). qPCR analysis of the re-
sulting neuroectoderm cultures revealed elevated expres-
sion of HOXA1 and HOXA2 prior to HOXB1, HOXB2, and
HOXB4. Immunocytochemical analysis revealed that early
cultures were HOXB1+/HOXB4 (2 hr FGF8b/CHIR, 4 days
RA; 63% ± 6%HOXB1+) but rapidly lost HOXB1 expression
if derived after only an additional 4 hr of NMP propagation
(6 hr FGF8b/CHIR, 4 days RA; 5% ± 2% HOXB1+) (Fig-
ure 3C). If neuroectoderm was derived after 24 hr of NMP
propagation, it reacquired HOXB1 and now also expressed
HOXB4 (24 hr FGF8b/CHIR, 4 days RA; 63% ± 5%HOXB1+
and 37% ± 8% HOXB4+) (Figure 3C). This mirrors HOX TF
expression during development of the fourth, fifth, and
sixth through eighth rhombomeres, respectively, indi-
cating that transitioning from Wnt/FGF to RA at the 2- to
4-hr time point generates HOXB1+ neuroectoderm that
could potentially produce facial nerve MNs whereasrs
Figure 3. RA Induces a Neuroectodermal Fate and Halts Colinear HOX Activation
(A) NMPs exposed to RA or CHIR acquire a neuroectodermal or mesodermal fate as assessed by flow cytometry at day 6 (gray histogram,
IgG control; red histogram, antigen of interest).
(B) Schematic for transition from NMPs to neuroectoderm by RA treatment. ‘‘t’’ indicates time under Wnt, FGF, and GDF signaling prior to
RA treatment, which halts HOX progression to yield a defined rostrocaudal identity.
(C and D) Representative hindbrain (C) and spinal cord (D) cultures assessed by qPCR, immunocytochemistry, and flow cytometry. For all
plots, flow cytometry data are presented as mean ± SD from biological duplicates, and qPCR data are mean ± SD from technical duplicates
normalized to the time point of maximum expression for each gene. For hindbrain cultures, HOXB1 and HOXB4 were quantified by
immunocytochemistry relative to DAPI+ nuclei (technical triplicates per time point, minimum 10,000 cells counted, and relative HOX
expression patterns were qualitatively verified across biological duplicates), while SOX2 and PAX6 were quantified by flow cytometry. For
spinal cord cultures, HOXD10 was quantified by immunocytochemistry relative to DAPI+ nuclei (technical duplicates, >2,000 cells
counted), while SOX2, PAX6, and HOXB4 were quantified by flow cytometry. Scale bars, 100 mm. For (D), dorsomorphin was included with
GDF11 and throughout RA treatment (further details in Figure S3).
(E) Mass spectrometry comparison of HOX profiles in cervical, thoracic, and lumbar neuroectoderm cultures. Cervical differentiation: 1 day
FGF8b, 2 days FGF8b/CHIR, 4 days RA; thoracic differentiation: 1 day FGF8b, 6 days FGF8b/CHIR, 4 days RA; lumbar differentiation: 1 day
FGF8b, 4 days FGF8b/CHIR, 2 days FGF8b/CHIR/GDF11, 4 days RA. Biological triplicates (neuroepithelium isolated individually from
three separate culture wells) were used to calculate statistical significance between cervical, thoracic, and lumbar samples.
Data are presented as mean ± SD and statistical significance was calculated using the Student’s unpaired t test. *p < 0.01; **p < 0.002;
***p < 0.0001.
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transitioning at 24 hr generates HOXB4+ neuroectoderm of
the caudal hindbrain (Bell et al., 1999; Philippidou and
Dasen, 2013; Bel-Vialar et al., 2002). Interestingly, the
high percentage of HOXB1+ cells at the 2 hrmark coincided
with low HOXB1 expression (10% of the maximum
observed expression at 20 hr) suggesting that while tran-
script levels are useful for identifying relative HOX gene
expression, they may not be directly instructive for pre-
dicting HOX TF profiles that arise due to cross-repressive
interactions (Bell et al., 1999; Dasen et al., 2003, 2005).
Also, the observed abrupt transitions in neuroectoderm
HOX TF expression suggest fairly uniform progressive
HOX activation within the NMPs (Figure 3C).
Next, we performed a similar Wnt/FGF/GDF-to-RA
transition time-course analysis focusing on later time
points that would generate neuroectoderm patterned to
spinal cord domains (Figures 3B and 3D). qPCR analysis
again demonstrated that RA treatment could halt the in-
duction of 50 paralogs that would otherwise have become
expressed in continuous Wnt/FGF/GDF11 treatment.
Using both immunocytochemistry and flow cytometry,
we observed uniform HOXB4 expression in neuroectoder-
mal cultures derived from NMPs transitioned to RA after
24–48 hr of propagation, correlating to a rostral cervical
spinal cord domain (Figures 3B and 3D). HOXB4 expres-
sion dropped sharply (from 84% ± 10% down to 12% ±
4% HOXB4+ cells) when the transition to RA occurred
at 72 hr (Figure 3D), which coincided with the initiation
of thoracic HOXC9 expression, a known repressor of
HOX4 paralog expression (Jung et al., 2010). Further-
more, HOXD10 was only detected in neuroectodermal
cultures when RA was added after 144 hr of NMP pro-
pagation (Figures 3B and 3D; Figure S3E), while HOXB4
remained repressed. Additional insights into the diversity
of HOX expression in neuroectoderm patterned to cervi-
cal, thoracic, and lumbar spinal cord domains were ob-
tained using quantitative mass spectrometry (Figure 3E;
Table S1). As expected, HOXC9 was expressed in thoracic
neuroectoderm but repressed in the HOXD10+ lumbar
culture, and many (HOXB1, HOXB4, HOXD4, HOXB5,
HOXB8, HOXC9, and HOXA10) but not all (HOXB9)
detected HOX factors exhibited expression patterns indic-
ative of similar cross-repressive interactions (Dasen et al.,
2005) (Figure 3E). Thus, these results demonstrate re-
gion-specific patterning of hPSC-derived neuroectoderm
in the spinal cord, and similar to the hindbrain neuro-
ectoderm cultures, repression of HOX proteins occurred
even though their HOX transcripts remained expressed,
possibly indicating cross-repressive interactions at this
stage are occurring at the post-transcriptional stage (Yekta
et al., 2004). Hence, our temporal biphasic approach for
differentiating hPSCs to neuroectoderm through a stable
NMP intermediate enables deterministic HOX patterning638 Stem Cell Reports j Vol. 4 j 632–644 j April 14, 2015 j ª2015 The Authoto impart diverse and discrete hindbrain and spinal cord
regional identities (Figure 3B).
Neuroectoderm with Region-Specific HOX Profiles
Generate Regional MN Populations
We used MN differentiation to evaluate whether the
regional specification imparted by our HOX patterning
approach yielded characteristic differences in the neuroec-
toderm progeny. First, we verified that MNs derived from
neuroectoderm of discrete hindbrain domains likewise
exhibited distinct HOX signatures. Hindbrain neuromeso-
dermwas propagated for 4, 12, and 24 hr before conversion
to ventralized neuroectoderm using RA, sonic hedgehog
(SHH) and purmorphamine (PM, a sonic hedgehog
agonist) exposure and further differentiation to MNs using
media containing RA and neurotrophic factors (NTFs). MN
differentiation was verified by the presence of cells co-
expressing bIII-tubulin/ISL1 and SMI-32 reactive non-
phosphorylated neurofilament heavy chain with ISL1 or
synapsin (Amoroso et al., 2013; Li et al., 2005) (Figure 4A).
Immunocytochemical analysis of HB9+ MNs generated
from 4 hr neuromesoderm revealed no co-expression
of HOXB1 or HOXB4. However, HB9+ MNs generated
from 12 hr neuromesoderm predominantly co-expressed
HOXB1 but not HOXB4, and those generated from
24 hr neuromesoderm predominantly co-expressed both
HOXB1 and HOXB4 (Figure 4A). Also, within all cultures,
many ISL1+ cells co-expressed PHOX2B indicative of hind-
brain identity (Maury et al., 2014; Pattyn et al., 2000).
Thus, MNs derived from hindbrain neuroectoderm with
discrete Hox gene and protein profiles (Figure 3C) likewise
express distinct HOX profiles, although the precise
regional identity of these MNs based on their HOX signa-
tures is currently unclear.
In the developed spinal cord, MNs reside in distinct mo-
tor columns: the lateral (LMC) and medial motor columns
(MMC) at cervical and lumbar levels, and the preganglionic
(PGC), MMC, and hypaxial motor column (HMC) at
thoracic levels (Philippidou and Dasen, 2013). MMC MNs
exclusively express LHX3 along with HB9 and ISL1, while
LMC MNs express LHX1 and FOXP1 with either HB9 or
ISL1 depending on their further subdivision into medial
and lateral domains (Thaler et al., 1999; Tsuchida et al.,
1994). PGC MNs are FOXP1+/ISL1+/HB9, while HMC
MNs are LHX3/FOXP1 but express both HB9 and ISL1
(Dasen et al., 2008;William et al., 2003). Thus, quantitative
immunocytochemistry can be used to observe whether
cervical, thoracic, and lumbar neuroectoderm could be
differentiated into MN precursors populations exhibiting
relative FOXP1/HB9 co-expression patterns characteristic
of their R/C domain in vivo, i.e., the presence of FOXP1+/
HB9+ cells in cervical and lumbar but not thoracic cultures
(Dasen et al., 2008).rs
Figure 4. Derivation of Region-Specific MNs
(A) Neuronal maturation from various hindbrain locales. NMPs were propagated for 4, 12, or 24 hr before conversion to ventralized
neuroectoderm and differentiation to neurons. DAPI (blue) is overlaid in most images. Scale bars, 20 mm. Quantified data are presented as
mean ± SD (four technical replicates, >100 HB9+ cells counted per sample).
(B) Evaluation of FOXP1 columnar identity in ISL1+ and HB9+ MNs. Cervical differentiation (C): 1 day FGF8b, 2 days FGF8b/CHIR; thoracic
differentiation (T): 1 day FGF8b, 5 days FGF8b/CHIR; lumbar differentiation (L): 1 day FGF8b, 4 days FGF8b/CHIR, 2 days FGF8b/CHIR/
GDF11; prior to en bloc passage and further differentiation as indicated. NTFs, neurotrophic factors (described in Experimental Pro-
cedures). For plotted data, open circles are percentages from individual fields and bars indicate the mean. Statistical significance was
calculated using the Student’s unpaired t test (three to five fields were counted across three biological replicates for each condition,
minimum 2,500 cells counted). n.s., p > 0.02; **p < 0.000001. Scale bars, 100 mm.
(C) Neuronal maturation from cervical, thoracic, and lumbar patterned neuroectoderm corresponding to the NMP state described in (B).
DAPI is overlaid in all images. Scale bars, 20 mm. RT-PCR (50 cycles) demonstrates maintenance of regional identity.Regional spinal MN precursors were derived by exposing
appropriately patterned NMPs to RA and PM for 7 days
prior to an additional week of differentiation in neuro-
trophic factors (Li et al., 2005) (Figure 4B). We observedStemno significant differences in the numbers of FOXP1+/
ISL1+ MN precursors (37% ± 9%, 27% ± 13%, and 26% ±
8%, respectively, of the total ISL1+ population). However,
FOXP1+/HB9+ MN precursors were prevalent in cervicalCell Reports j Vol. 4 j 632–644 j April 14, 2015 j ª2015 The Authors 639
and lumbar cultures (23% ± 6% and 18% ± 4% of the
total HB9+ population) but scarce in thoracic cultures
(8% ± 4%; p < 0.000001, Figure 4B). We initially expected
that no FOXP1+/HB9+ MN precursors would be present
in the thoracic cultures, but PGC MNs proceed through
an HB9+ state before its expression is rapidly lost (William
et al., 2003). Therefore, the small subset of FOXP1+/HB9+
cells in our thoracic cultures likely represents immature
PGC MNs. The significant difference in the propensity
of cervical and lumbar versus thoracic neuroectoderm to
generate FOXP1+/HB9+ MN precursors characteristic of
the LMC demonstrates proper regional specification as a
result of our deterministic HOX patterning approach.
Furthermore, we investigated whether accelerated
MN differentiation induced by treating ventralized cervi-
cal (HOXC6+/HOXC9/HOXD10), thoracic (HOXC6+/
HOXC9+/HOXD10), and lumbar (HOXC6+/HOXC9+/
HOXD10+) (Figure 3D) neuroectoderm with the Notch
signaling inhibitor DAPT (Maury et al., 2014), which
yielded >92% NeuN+ neuronal cultures within 7 days (Fig-
ures 4C and S4A), altered the regional specification
imposed at the neuroectoderm stage. Each differentiated
culture contained MNs co-expressing bIII-tubulin with
ISL1 or HB9 and SMI-32 with ISL1 or synapsin (Figure 4C).
RT-PCR analysis revealed that each culture’s regional
spinal cord identity patterned at the neuroectodermal
state was preserved throughout accelerated neuronal
differentiation (Figure 4C). Also, electrophysiological
analysis of these cervical, thoracic, and lumbar cultures
after additional weeks of maturation determined that
each region-specific culture possessed neurons exhibiting
mature action potentials (Figures S4B and S4C). Hence,
our approach to deterministic patterning of HOX expres-
sion should be broadly applicable to deriving functional
and region-specific hindbrain and spinal cord tissues
from hPSCs.DISCUSSION
Regulation ofHOX Expression during Posterior Neural
Differentiation of hPSCs
Our results provide unique evidence that HOX expression
during posterior neural differentiation of hPSCs can be
precisely regulated by temporal control of two opposing
mechanisms. Wnt/b-catenin, FGF, and GDF signaling
synergistically control colinear HOX activation while
maintaining an NMP state, and RA arrests HOX activation
to yield a fixed R/C position and transitions the cultures
to definitive neuroectoderm. This approach should enable
the derivation of neuroectoderm from any R/C position
spanning the hindbrain to lumbosacral spinal cord in a
predictable manner.640 Stem Cell Reports j Vol. 4 j 632–644 j April 14, 2015 j ª2015 The AuthoSpecifically, we have demonstrated the ability to generate
neuroectoderm with HOX profiles corresponding to spe-
cific rhombomeric segments and cervical, thoracic, and
lumbosacral vertebral segments. Our findings are distinct
from other PSC neural differentiation approaches that un-
predictably pattern cells to primarily caudal hindbrain thru
cervicalHOX profiles (Amoroso et al., 2013; Lee et al., 2007;
Li et al., 2005) or to heterogeneous mixtures of cervical,
thoracic, and lumbar tissues (Patani et al., 2011; Peljto
et al., 2010). Given the data presented in our manuscript,
it is perhaps surprising that RA-only patterning approaches
can yield HOX6-8 expression, but this may be inherent to
the choice of differentiation methods. Whereas we utilized
a chemically defined monolayer system to screen HOX
patterning cues, most other studies have used embryoid
body (EB) cultures for posterior neural differentiation. EB
differentiation has been shown to activate endogenous
Wnt signaling (Li et al., 2009), but cells in outer layers of
EBs are exposed to different concentrations of soluble
media cues than those on the inside of EBs due to diffu-
sional limitations (Van Winkle et al., 2012). Therefore, we
suspect in these EB-based systems that competition be-
tween endogenous Wnt (activating HOX progression) and
exogenously added RA (inducing HOX arrest and neural
differentiation) could cause heterogeneous R/C patterning,
especially when considering relative heterogeneity in EB
sizes and shapes. In contrast, exposure to soluble factors
in our monolayer differentiation system should be more
uniform, possibly enabling our enhanced HOX patterning
precision.
We also provide evidence that Wnt/b-catenin and FGF
signaling alone can induce substantial expression of CDX
genes, which are core regulators ofHOX expression in vivo,
similar to results from tissue explant and other PSC differ-
entiation studies (Gouti et al., 2014; Maury et al., 2014;
Mazzoni et al., 2013; Nordstro¨m et al., 2006). Thus, RA
and Wnt/FGF signaling may regulate different epigenetic
states, which could potentially explain discrepancies
between reports of coarse, saltatory HOX activation
in vitro by RA alone (Mazzoni et al., 2013) versus the induc-
tion of organized, colinear HOX activation in vivo by the
temporal integration of multiple signaling pathways.
Moreover, though previous studies have suggested RA
serves as a ‘‘rostralizing’’ factor (Philippidou and Dasen,
2013), our treatment of thoracic or lumbosacral NMPs
with RA did not generate rostralized neuroectoderm (Fig-
ure 3D); as such, we postulate these previous studies were
actually observing premature termination of HOX progres-
sion. From our results, we posit that HOX patterning may
involve a temporal, biphasic mechanism where Wnt/FGF
primarily controls colinearHOX activation and RA controls
its termination. This is different than the widely cited
gradient mechanism that supposes RA controls 30 HOXrs
patterning andWnt/FGF controls 50 HOX patterning (Phil-
ippidou and Dasen, 2013). Our patterning mechanism
resonates with a progress/stem zone model that has been
heavily scrutinized for limb development (Towers and
Tickle, 2009). However, our in vitro approach does not
allow us to draw direct conclusions about the role each of
these factors plays in HOX regulation in vivo. We are
instead hopeful that our patterning approach will enable
detailed studies of HOX regulation in vitro, which could
then be used to conduct more informative studies of
HOX patterning in vivo. In addition, since much of the
‘‘Hoxasome’’ is still poorly understood (Mann et al.,
2009), the scalability of our chemically defined, deter-
ministic HOX patterning protocol will be invaluable to
elucidating the molecular mechanisms underlying Hox
regulation of downstream neural cell fates.
Implications for Regenerative Therapies
and Disease Modeling
Recent studies of cell replacement therapy in the anterior
CNS using hPSC-derived progenitors have demonstrated
that the implanted cells must possess a regional phenotype
that mimics endogenous tissues in order to effectively
engraft and correct neural deficits (Kriks et al., 2011; Ma
et al., 2012). Since HOX expression patterns are crucial de-
terminants of cellular phenotype, organization, and neural
circuit integration in the developing hindbrain and spinal
cord (Philippidou and Dasen, 2013), our patterning
approach could serve as the basis for generating a spectrum
of posterior neural progeny with highly specific regional
identities that may aid regenerative therapy efforts. Also,
regional MN phenotypes exhibit differential susceptibility
to several neurodegenerative disorders, including amyotro-
phic lateral sclerosis (ALS) and spinal muscular atrophy
(SMA) (Brockington et al., 2013; Kaplan et al., 2014). Our
deterministic HOX patterning approach will facilitate
elucidation of the molecular basis underlying differential
susceptibility of iPSC-derived MNs with the same disease-
causing mutations but different regional phenotypes,
including previously inaccessible hindbrain phenotypes.
The ability to execute such experimental paradigms should
significantly enhance the utility of iPSC-derived MN
disease models to identify relevant pathways of neurode-
generative disease induction and progression (Chen et al.,
2014; Kiskinis et al., 2014).EXPERIMENTAL PROCEDURES
Induction and Propagation of NMPs and
Differentiation to Neural Fates
H9 hESCs (Thomson et al., 1998) (passage 25–45), H9 ishcat2
hESCs (Lian et al., 2012) (passage 33–43), and IMR90-4 iPSCs
(Yu et al., 2007) (passage 31–40) were maintained in E8 mediumStemon Matrigel (BD Biosciences) as previously described (Lippmann
et al., 2014). 2 mg/ml doxycycline (Sigma) was used for b-catenin
knockdown in the ishcat2 line. To initiate differentiation, hPSCs
were passaged with accutase (Life Technologies) onto vitronectin
(VTN-NC)-coated (Chen et al., 2011) plates at a density of 1 3
105 cells/cm2 with 10 mMROCK inhibitor (Y27632; R&D Systems)
as previously described (Lippmann et al., 2014). The following day,
cells were changed to E6medium and then changed to E6medium
containing 200 ng/ml FGF8b 24 hr later (PeproTech). After another
day, the cells were washed once with 2ml PBS, accutased for 2min,
and removed from the surface by gentle pipetting. After collection
by centrifugation, cells were gently resuspended in E6 medium
containing 200 ng/ml FGF8b and CHIR99021 (CHIR, 3 mM for H9
hESCs and 2 mM for IMR90-4 iPSCs; R&D Systems) and re-seeded
on VTN-NC-coated plates at a density of 1.5 3 105 cells/cm2.
10 mM Y27632 was included during the re-seeding process, and
the medium was not changed again until 48 hr after passaging.
If extended NMP propagation was required, this passaging process
was repeated on day 3 of CHIR treatment (re-seed density of 1.2 3
105 cells/cm2), and 50 ng/ml GDF11 (PeproTech) was added on
day 4 of CHIR treatment to initiate lumbosacral patterning.
For some experiments, 1 mM dorsomorphin (R&D Systems) was
included with GDF11. At any point during CHIR treatment, cells
were changed to E6 medium containing 1 mM retinoic acid (RA;
Sigma) to elicit neural induction and arrest HOX progression. For
assessment of FOXP1 expression in MN precursors, NMPs were
passaged en bloc by scraping and re-seeded in VTN-NC-coated
chamber slides at a 1:200 ratio in E6 medium containing 1 mM
RA and 100 nM purmorphamine (PM; Cayman Chemicals) for
7 days, followed by an additional 7-day treatment with 10 ng/ml
brain-derived neurotrophic factor (BDNF; PeproTech), 10 ng/ml
glial-derived neurotrophic factor (GDNF; PeproTech), and cAMP
(1 mM; Sigma). For assessment of HOX identity in MNs, NMPs
were neuralized and ventralized with 1 mM RA, 2 mM PM, and
1 mg/ml sonic hedgehog (SHH; R&D Systems) for 2 days and
then passaged en bloc or with accutase and re-seeded in VTN-
NC-coated chamber slides at 23 104 cells/cm2 in E6 medium con-
taining RA, 10 mM Y27632, 10 ng/ml BDNF, 10 ng/ml GDNF, and
1 mM cAMP for 7–14 days (Y27632 was removed after the first
3 days). 10 nM RA was used for cultures with hindbrain HOX
signatures, and 1 mM RA was used for cultures with spinal cord
HOX signatures. 1 mM DAPT (Cayman Chemicals) was included
for cultures with spinal cord identity. For extended neuronal
differentiation to conduct electrophysiology studies, NMPs were
neuralized and ventralized with 1 mM RA, 2 mM PM, and 1 mg/ml
SHH, passaged 1:100 onto Matrigel-coated glass coverslips, and
cultured for 7 days in E6 medium containing 1 mM RA, 100 nM
PM, 100 ng/ml SHH, and 1 mM DAPT. The cultures were then
matured in E6 medium containing 10 ng/ml BDNF, 10 ng/ml
GDNF, and 1 mM cAMP for at least 2 months prior to electrophys-
iology measurements. The cells were supplemented with 1 mg/ml
mouse laminin (Invitrogen) once per week to help maintain
attachment.
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